Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares-Reference-Cited by-同舟云学术

Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares

Published:2022-10-11 Issue:14 Volume:328 Page:1458
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Jorge April M.¹,Mancini Christian¹,Zhou Baijun¹,Ho Gary²,Zhang Yuqing¹,Costenbader Karen³,Choi Hyon K.¹

Affiliation:

1. Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston

2. Division of Rheumatology, NYU Langone Health, New York

3. Division of Rheumatology, Inflammation and Immunity, Brigham and Women’s Hospital, Boston, Massachusetts

Abstract

This study of an academic medical center patient cohort with systemic lupus erythematosus (SLE) investigates the association between hydroxychloroquine dose based on current guidelines and risk of lupus flares.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2796634/jama_jorge_2022_ld_220053_1664819905.7546.pdf

Reference6 articles.

1. 2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus.;Fanouriakis;Ann Rheum Dis,2019

2. Hydroxychloroquine retinopathy—implications of research advances for rheumatology care.;Jorge;Nat Rev Rheumatol,2018

3. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision).;Marmor;Ophthalmology,2016

4. Combined oral contraceptives in women with systemic lupus erythematosus.;Petri;N Engl J Med,2005

5. Measures of adult systemic lupus erythematosus: disease activity and damage.;Arora;Arthritis Care Res (Hoboken),2020

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal;Joint Bone Spine;2024-12

2. French protocol for the diagnosis and management of systemic lupus erythematosus;La Revue de Médecine Interne;2024-09

3. Erfolgreiche Therapie des systemischen Lupus erythematodes (SLE);Nephrologie aktuell;2024-09

4. Relation between hydroxychloroquine dose and continuation rate in patients with systemic lupus erythematosus;Modern Rheumatology;2024-08-06

5. The Hydroxychloroquine Conundrum: Striking the Right Balance Between Safety and Efficacy in Rheumatology Practice;Arthritis & Rheumatology;2024-07-02